医学
沙库比林、缬沙坦
缬沙坦
沙库比林
心力衰竭
内科学
心脏病学
重症监护医学
射血分数
血压
作者
Henri Lu,Brian Claggett,Milton Packer,Carolyn S.P. Lam,Karl Swedberg,Jean L. Rouleau,Michael R. Zile,Martin Lefkowitz,Akshay S. Desai,Pardeep S. Jhund,John J.V. McMurray,Scott D. Solomon,Muthiah Vaduganathan
标识
DOI:10.1001/jamacardio.2024.2566
摘要
Sacubitril/valsartan is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalizations in patients with chronic HF. However, many of these patients are older and have multiple comorbidities that increase the risk of hospitalization for causes other than HF.
科研通智能强力驱动
Strongly Powered by AbleSci AI